Advanced Parenteral Drug Delivery Devices-EMEA Market Status and Trend Report 2013-2023
Report Summary
Advanced Parenteral Drug Delivery Devices-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Advanced Parenteral Drug Delivery Devices industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Advanced Parenteral Drug Delivery Devices 2013-2017, and development forecast 2018-2023
Main market players of Advanced Parenteral Drug Delivery Devices in EMEA, with company and product introduction, position in the Advanced Parenteral Drug Delivery Devices market
Market status and development trend of Advanced Parenteral Drug Delivery Devices by types and applications
Cost and profit status of Advanced Parenteral Drug Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the EMEA Advanced Parenteral Drug Delivery Devices market as:
EMEA Advanced Parenteral Drug Delivery Devices Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Advanced Parenteral Drug Delivery Devices Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
EMEA Advanced Parenteral Drug Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Genito-Urinary Agents
EMEA Advanced Parenteral Drug Delivery Devices Market: Players Segment Analysis (Company and Product introduction, Advanced Parenteral Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Advanced Parenteral Drug Delivery Devices-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Advanced Parenteral Drug Delivery Devices industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Advanced Parenteral Drug Delivery Devices 2013-2017, and development forecast 2018-2023
Main market players of Advanced Parenteral Drug Delivery Devices in EMEA, with company and product introduction, position in the Advanced Parenteral Drug Delivery Devices market
Market status and development trend of Advanced Parenteral Drug Delivery Devices by types and applications
Cost and profit status of Advanced Parenteral Drug Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the EMEA Advanced Parenteral Drug Delivery Devices market as:
EMEA Advanced Parenteral Drug Delivery Devices Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Advanced Parenteral Drug Delivery Devices Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
EMEA Advanced Parenteral Drug Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Genito-Urinary Agents
EMEA Advanced Parenteral Drug Delivery Devices Market: Players Segment Analysis (Company and Product introduction, Advanced Parenteral Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
1.1 Definition of Advanced Parenteral Drug Delivery Devices in This Report
1.2 Commercial Types of Advanced Parenteral Drug Delivery Devices
1.2.1 Prefillable Syringes
1.2.2 Injectors Cartridges
1.2.3 Hypodermic Syringes
1.2.4 IV Catheters
1.2.5 Other Parenteral Delivery Devices
1.3 Downstream Application of Advanced Parenteral Drug Delivery Devices
1.3.1 Central Nervous System Agents
1.3.2 Respiratory Agents
1.3.3 Hormones & Related Agents
1.3.4 Gastrointestinal Agents
1.3.5 Cardiovascular Agents
1.3.6 Anti-Infective Agents
1.3.7 Nutritional Agents
1.3.8 Genito-Urinary Agents
1.4 Development History of Advanced Parenteral Drug Delivery Devices
1.5 Market Status and Trend of Advanced Parenteral Drug Delivery Devices 2013-2023
1.5.1 EMEA Advanced Parenteral Drug Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Advanced Parenteral Drug Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Advanced Parenteral Drug Delivery Devices in EMEA 2013-2017
2.2 Consumption Market of Advanced Parenteral Drug Delivery Devices in EMEA by Regions
2.2.1 Consumption Volume of Advanced Parenteral Drug Delivery Devices in EMEA by Regions
2.2.2 Revenue of Advanced Parenteral Drug Delivery Devices in EMEA by Regions
2.3 Market Analysis of Advanced Parenteral Drug Delivery Devices in EMEA by Regions
2.3.1 Market Analysis of Advanced Parenteral Drug Delivery Devices in Europe 2013-2017
2.3.2 Market Analysis of Advanced Parenteral Drug Delivery Devices in Middle East 2013-2017
2.3.3 Market Analysis of Advanced Parenteral Drug Delivery Devices in Africa 2013-2017
2.4 Market Development Forecast of Advanced Parenteral Drug Delivery Devices in EMEA 2018-2023
2.4.1 Market Development Forecast of Advanced Parenteral Drug Delivery Devices in EMEA 2018-2023
2.4.2 Market Development Forecast of Advanced Parenteral Drug Delivery Devices by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Advanced Parenteral Drug Delivery Devices in EMEA by Types
3.1.2 Revenue of Advanced Parenteral Drug Delivery Devices in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Advanced Parenteral Drug Delivery Devices in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Advanced Parenteral Drug Delivery Devices in EMEA by Downstream Industry
4.2 Demand Volume of Advanced Parenteral Drug Delivery Devices by Downstream Industry in Major Countries
4.2.1 Demand Volume of Advanced Parenteral Drug Delivery Devices by Downstream Industry in Europe
4.2.2 Demand Volume of Advanced Parenteral Drug Delivery Devices by Downstream Industry in Middle East
4.2.3 Demand Volume of Advanced Parenteral Drug Delivery Devices by Downstream Industry in Africa
4.3 Market Forecast of Advanced Parenteral Drug Delivery Devices in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
5.1 EMEA Economy Situation and Trend Overview
5.2 Advanced Parenteral Drug Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 6 ADVANCED PARENTERAL DRUG DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Advanced Parenteral Drug Delivery Devices in EMEA by Major Players
6.2 Revenue of Advanced Parenteral Drug Delivery Devices in EMEA by Major Players
6.3 Basic Information of Advanced Parenteral Drug Delivery Devices by Major Players
6.3.1 Headquarters Location and Established Time of Advanced Parenteral Drug Delivery Devices Major Players
6.3.2 Employees and Revenue Level of Advanced Parenteral Drug Delivery Devices Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ADVANCED PARENTERAL DRUG DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.1.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 Amgen
7.2.1 Company profile
7.2.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.2.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Amgen
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.3.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Hoffmann-La Roche
7.4.1 Company profile
7.4.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.4.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche
7.5 AstraZeneca
7.5.1 Company profile
7.5.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.5.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of AstraZeneca
7.6 Baxter
7.6.1 Company profile
7.6.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.6.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Baxter
7.7 Dickinson
7.7.1 Company profile
7.7.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.7.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Dickinson
7.8 Boston Scientific
7.8.1 Company profile
7.8.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.8.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Boston Scientific
7.9 Bristol-Myers Squibb
7.9.1 Company profile
7.9.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.9.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.10 GlaxoSmithKline
7.10.1 Company profile
7.10.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.10.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.11 Novartis
7.11.1 Company profile
7.11.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.11.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Novartis
7.12 Becton
7.12.1 Company profile
7.12.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.12.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Becton
7.13 AptarGroup
7.13.1 Company profile
7.13.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.13.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of AptarGroup
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
8.1 Industry Chain of Advanced Parenteral Drug Delivery Devices
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
9.1 Cost Structure Analysis of Advanced Parenteral Drug Delivery Devices
9.2 Raw Materials Cost Analysis of Advanced Parenteral Drug Delivery Devices
9.3 Labor Cost Analysis of Advanced Parenteral Drug Delivery Devices
9.4 Manufacturing Expenses Analysis of Advanced Parenteral Drug Delivery Devices
CHAPTER 10 MARKETING STATUS ANALYSIS OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Advanced Parenteral Drug Delivery Devices in This Report
1.2 Commercial Types of Advanced Parenteral Drug Delivery Devices
1.2.1 Prefillable Syringes
1.2.2 Injectors Cartridges
1.2.3 Hypodermic Syringes
1.2.4 IV Catheters
1.2.5 Other Parenteral Delivery Devices
1.3 Downstream Application of Advanced Parenteral Drug Delivery Devices
1.3.1 Central Nervous System Agents
1.3.2 Respiratory Agents
1.3.3 Hormones & Related Agents
1.3.4 Gastrointestinal Agents
1.3.5 Cardiovascular Agents
1.3.6 Anti-Infective Agents
1.3.7 Nutritional Agents
1.3.8 Genito-Urinary Agents
1.4 Development History of Advanced Parenteral Drug Delivery Devices
1.5 Market Status and Trend of Advanced Parenteral Drug Delivery Devices 2013-2023
1.5.1 EMEA Advanced Parenteral Drug Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Advanced Parenteral Drug Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Advanced Parenteral Drug Delivery Devices in EMEA 2013-2017
2.2 Consumption Market of Advanced Parenteral Drug Delivery Devices in EMEA by Regions
2.2.1 Consumption Volume of Advanced Parenteral Drug Delivery Devices in EMEA by Regions
2.2.2 Revenue of Advanced Parenteral Drug Delivery Devices in EMEA by Regions
2.3 Market Analysis of Advanced Parenteral Drug Delivery Devices in EMEA by Regions
2.3.1 Market Analysis of Advanced Parenteral Drug Delivery Devices in Europe 2013-2017
2.3.2 Market Analysis of Advanced Parenteral Drug Delivery Devices in Middle East 2013-2017
2.3.3 Market Analysis of Advanced Parenteral Drug Delivery Devices in Africa 2013-2017
2.4 Market Development Forecast of Advanced Parenteral Drug Delivery Devices in EMEA 2018-2023
2.4.1 Market Development Forecast of Advanced Parenteral Drug Delivery Devices in EMEA 2018-2023
2.4.2 Market Development Forecast of Advanced Parenteral Drug Delivery Devices by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Advanced Parenteral Drug Delivery Devices in EMEA by Types
3.1.2 Revenue of Advanced Parenteral Drug Delivery Devices in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Advanced Parenteral Drug Delivery Devices in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Advanced Parenteral Drug Delivery Devices in EMEA by Downstream Industry
4.2 Demand Volume of Advanced Parenteral Drug Delivery Devices by Downstream Industry in Major Countries
4.2.1 Demand Volume of Advanced Parenteral Drug Delivery Devices by Downstream Industry in Europe
4.2.2 Demand Volume of Advanced Parenteral Drug Delivery Devices by Downstream Industry in Middle East
4.2.3 Demand Volume of Advanced Parenteral Drug Delivery Devices by Downstream Industry in Africa
4.3 Market Forecast of Advanced Parenteral Drug Delivery Devices in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
5.1 EMEA Economy Situation and Trend Overview
5.2 Advanced Parenteral Drug Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 6 ADVANCED PARENTERAL DRUG DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Advanced Parenteral Drug Delivery Devices in EMEA by Major Players
6.2 Revenue of Advanced Parenteral Drug Delivery Devices in EMEA by Major Players
6.3 Basic Information of Advanced Parenteral Drug Delivery Devices by Major Players
6.3.1 Headquarters Location and Established Time of Advanced Parenteral Drug Delivery Devices Major Players
6.3.2 Employees and Revenue Level of Advanced Parenteral Drug Delivery Devices Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ADVANCED PARENTERAL DRUG DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.1.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 Amgen
7.2.1 Company profile
7.2.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.2.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Amgen
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.3.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Hoffmann-La Roche
7.4.1 Company profile
7.4.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.4.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche
7.5 AstraZeneca
7.5.1 Company profile
7.5.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.5.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of AstraZeneca
7.6 Baxter
7.6.1 Company profile
7.6.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.6.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Baxter
7.7 Dickinson
7.7.1 Company profile
7.7.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.7.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Dickinson
7.8 Boston Scientific
7.8.1 Company profile
7.8.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.8.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Boston Scientific
7.9 Bristol-Myers Squibb
7.9.1 Company profile
7.9.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.9.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.10 GlaxoSmithKline
7.10.1 Company profile
7.10.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.10.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
7.11 Novartis
7.11.1 Company profile
7.11.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.11.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Novartis
7.12 Becton
7.12.1 Company profile
7.12.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.12.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Becton
7.13 AptarGroup
7.13.1 Company profile
7.13.2 Representative Advanced Parenteral Drug Delivery Devices Product
7.13.3 Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin of AptarGroup
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
8.1 Industry Chain of Advanced Parenteral Drug Delivery Devices
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
9.1 Cost Structure Analysis of Advanced Parenteral Drug Delivery Devices
9.2 Raw Materials Cost Analysis of Advanced Parenteral Drug Delivery Devices
9.3 Labor Cost Analysis of Advanced Parenteral Drug Delivery Devices
9.4 Manufacturing Expenses Analysis of Advanced Parenteral Drug Delivery Devices
CHAPTER 10 MARKETING STATUS ANALYSIS OF ADVANCED PARENTERAL DRUG DELIVERY DEVICES
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
